IQE
IQE · AIM · Technology · mcap £663m · 46.2p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 30 Sep 26 | Routine | Total Voting Rights | |
| 07 Sep 26 | Results | H1 2026 Interim Results
Revenue grew 43% to £64.6m in H1 2026, with adjusted EBITDA reaching £6.0m; company plans Main Market listing in H1 2027. |
+3.3% |
| 03 Sep 26 | Quintessent QDL purchase agreement
IQE extends supply agreement with Quintessent for Quantum Dot Laser epitaxy wafers supporting customer sampling. |
+2.3% | |
| 01 Sep 26 | Routine | Total Voting Rights | |
| 12 Aug 26 | Routine | Notice of Results | |
| 05 Aug 26 | Director dealing | Director/PDMR Shareholding | |
| 03 Aug 26 | Routine | Total Voting Rights | |
| 21 Jul 26 | Trading update | Trading Update
H1 2026 revenue exceeded expectations at £64m; FY26 guidance raised to over 30% growth |
+30.5% |
| 14 Jul 26 | $14m AI & datacentre production order
IQE secures $14 million multi-year production order from strategic technology customer for AI and datacentre applications. |
+4.9% | |
| 01 Jul 26 | Routine | Total Voting Rights and Block Admission | |
| 01 Jul 26 | Appointment of Non-executive Directors
MACOM appoints two representatives, Robert Dennehy and David O'Carroll, as Non-Executive Directors. |
−0.9% | |
| 30 Jun 26 | Result of AGM
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, is pleased to announce is pleased to announce that at its 2026 Annual Genera |
+1.1% | |
| 30 Jun 26 | Routine | Notice of AGM | |
| 25 Jun 26 | Holding | Holding(s) in Company | |
| 19 Jun 26 | Exercise of Warrants, Issue of Equity and TVR
Exercise of Warrants, Issue of Equity and TVR (Director/PDMR Shareholding) |
−0.4% | |
| 16 Jun 26 | Exercise of Warrants, Issue of Equity and TVR
Exercise of Warrants, Issue of Equity and TVR |
−3.0% | |
| 15 Jun 26 | Tower Semiconductor InP supply agreement
IQE secures multi-year InP epiwafer supply agreement with Tower Semiconductor for silicon photonics; resolves IP disputes. |
+22.6% | |
| 10 Jun 26 | Director Notification and AGM Update
Victoria Hull, Independent Non-Executive Director, will not stand for re-election at AGM on 30 June 2026. |
−4.7% | |
| 03 Jun 26 | Holding | Holding(s) in Company | |
| 03 Jun 26 | Routine | Notice of AGM and Annual Report | |
| 02 Jun 26 | Routine | Total Voting Rights | |
| 01 Jun 26 | Holding | Holding(s) in Company | |
| 29 May 26 | Director dealing | Director/PDMR Shareholding | |
| 28 May 26 | Results | FY 2025 Financial Results
FY25 revenue fell 18% to £97.3m; £81m fundraise completed with strategic investment from MACOM transforming balance sheet. |
−6.0% |
| 28 May 26 | Fundraise | Completion of Fundraising
IQE completes £81m fundraising with admission of new shares expected 1 June 2026. |
−6.0% |
| 20 May 26 | Routine | Notice of Results | |
| 18 May 26 | Holding | Holding(s) in Company | |
| 15 May 26 | Result of General Meeting
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, is pleased to announce that at its General Meeting, held today in London, al |
−7.3% | |
| 14 May 26 | Holding | Holding(s) in Company | |
| 12 May 26 | Holding | Holding(s) in Company | |
| 11 May 26 | Holding | Holding(s) in Company | |
| 07 May 26 | Holding | Holding(s) in Company | |
| 06 May 26 | Holding | Holding(s) in Company | |
| 05 May 26 | Holding | Holding(s) in Company | |
| 01 May 26 | Routine | Total Voting Rights | |
| 29 Apr 26 | Circular & Notice of General Meeting
Posting of Circular and Notice of General Meeting |
+0.4% | |
| 28 Apr 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
−18.5% | |
| 28 Apr 26 | Results | Results of Placing and Retail Offer
IQE closes £13m placing and retail offer; total fundraising reaches £81m including MACOM investment. |
−18.5% |
| 27 Apr 26 | RetailBook Offer
IQE announces conditional retail offer of new shares at 19.8 pence per share via RetailBook. |
+3.8% | |
| 27 Apr 26 | Conclusion of Strategic Review
IQE raises £81m from MACOM and other shareholders, concludes strategic review |
+3.8% | |
| 27 Apr 26 | Routine | Rule 2.9 Announcement | |
| 23 Apr 26 | Routine | Rule 2.9 Announcement | |
| 22 Apr 26 | Routine | Rule 2.9 Announcement | |
| 21 Apr 26 | Routine | Rule 2.9 Announcement | |
| 20 Apr 26 | Routine | Rule 2.9 Announcement | |
| 17 Apr 26 | Routine | Rule 2.9 Announcement | |
| 16 Apr 26 | Routine | Rule 2.9 Announcement | |
| 15 Apr 26 | Routine | Rule 2.9 Announcement | |
| 14 Apr 26 | Routine | Rule 2.9 Announcement | |
| 13 Apr 26 | Routine | Rule 2.9 Announcement | |
| 07 Apr 26 | Routine | Rule 2.9 Announcement | |
| 02 Apr 26 | Block Admission
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, today announces an application has been made to the London Stock Exchange fo |
−6.0% | |
| 01 Apr 26 | Routine | Rule 2.9 Announcement | |
| 01 Apr 26 | Routine | Total Voting Rights | |
| 30 Mar 26 | Routine | Rule 2.9 Announcement | |
| 27 Mar 26 | Routine | Rule 2.9 Announcement | |
| 26 Mar 26 | Holding | Holding(s) in Company | |
| 24 Mar 26 | Routine | Rule 2.9 Announcement | |
| 23 Mar 26 | Routine | Rule 2.9 Announcement | |
| 20 Mar 26 | Routine | Rule 2.9 Announcement | |
| 19 Mar 26 | Routine | Rule 2.9 Announcement | |
| 18 Mar 26 | Routine | Rule 2.9 Announcement | |
| 17 Mar 26 | Routine | Rule 2.9 Announcement | |
| 12 Mar 26 | Routine | Rule 2.9 Announcement | |
| 11 Mar 26 | Routine | Rule 2.9 Announcement | |
| 10 Mar 26 | Routine | Rule 2.9 Announcement | |
| 09 Mar 26 | Routine | Rule 2.9 Announcement | |
| 05 Mar 26 | Routine | Rule 2.9 Announcement | |
| 04 Mar 26 | Routine | Rule 2.9 Announcement | |
| 02 Mar 26 | Routine | Rule 2.9 Announcement - Replacement | |
| 02 Mar 26 | Routine | Total Voting Rights | |
| 02 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 02 Mar 26 | Routine | Rule 2.9 Announcement | |
| 18 Feb 26 | Routine | Rule 2.9 Announcement | |
| 06 Feb 26 | Holding | Holding(s) in Company | |
| 03 Feb 26 | Routine | Rule 2.9 Announcement | |
| 02 Feb 26 | Routine | Total Voting Rights | |
| 02 Feb 26 | Routine | Rule 2.9 Announcement | |
| 12 Jan 26 | Trading update | Trading Update
H2 2025 trading momentum from military, defence, AI and data centre markets; FY revenue c.£97m at upper end of guidance. |
+42.2% |
| 05 Jan 26 | Routine | Total Voting Rights and Block Admission | |
| 30 Dec 25 | Routine | Rule 2.9 Announcement | |
| 08 Dec 25 | Strategic supply agreement with Lumentum
IQE extends multi-year strategic supply agreement with Lumentum for epiwafer supply supporting advanced sensing technologies. |
+0.0% | |
| 01 Dec 25 | Routine | Total Voting Rights | |
| 01 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 13 Nov 25 | Routine | Rule 2.9 Announcement | |
| 11 Nov 25 | Routine | Rule 2.9 Announcement | |
| 06 Nov 25 | Routine | Rule 2.9 Announcement | |
| 31 Oct 25 | Routine | Total Voting Rights | |
| 24 Oct 25 | Holding | Holding(s) in Company | |
| 21 Oct 25 | Routine | Rule 2.9 Announcement | |
| 20 Oct 25 | Holding | Holding(s) in Company | |
| 20 Oct 25 | Holding | Holding(s) in Company | |
| 08 Oct 25 | Holding | Holding(s) in Company | |
| 07 Oct 25 | Routine | Form 8 (DD) - IQE plc | |
| 06 Oct 25 | Routine | Form 8 (DD) - IQE plc |
Company filings. Not investment advice.